Haloperidol decanoate in psychotic patients
Lagomarsino, A.J.
Acta Psiquiatrica y Psicologica de America Latina 33(3): 181
1987
ISSN/ISBN: 0001-6896 PMID: 3442249 Document Number: 288332
Document emailed within 1 workday
Related Documents
Ellerman, L.A. 1987: Open clinical trial with haloperidol decanoate in patients with psychotic disorders Acta Psiquiatrica y Psicologica de America Latina 33(2): 157-162Leff, J.P.; Tress, K.H. 1986: The response of untreated chronic schizophrenics to haloperidol and haloperidol decanoate International Clinical Psychopharmacology 1(Suppl 1): 27-40
Roncoroni, D. 1984: Long-term therapy of chronic schizophrenic patients with haloperidol decanoate Psychiatrische Praxis 11(2): 56-58
Taymeeyapradit, U.; Kuasirikul, S. 2002: Comparative study of the effectiveness of zuclopenthixol acetate and haloperidol in acutely disturbed psychotic patients Journal of the Medical Association of Thailand 85(12): 1301-1308
Malfroid, M.; Hens, L.; Roosen, P.; Dom, R. 1978: Double-blind- evaluation of bromperidol versus haloperidol treatment in chronic psychotic patients Acta Psychiatrica Belgica 78(1): 147-154
Zbytovský, J. 1993: Haloperidol decanoate (Janssen) in the treatment of schizophrenia Ceskoslovenska Psychiatrie 89(1): 27-29
Paolucci, S.; Buttinelli, C.; Ciani, S.; Fiume, S. 1982: 2 cases of Gilles de la Tourette's disease treated with haloperidol decanoate Minerva Psichiatrica 23(1): 59-61
Ereshefsky, L.; Saklad, S.R.; Tran-Johnson, T.; Toney, G.; Lyman, R.C.; Davis, C.M. 1990: Kinetics and clinical evaluation of haloperidol decanoate loading dose regimen Psychopharmacology Bulletin 26(1): 108-114
Cesková, E.; Svestka, J.; Rysánek, R. 1993: Intraindividual comparison of haloperidol decanoate and oxyprothepine in maintenance therapy in schizophrenic psychoses Ceskoslovenska Psychiatrie 89(1): 11-14
Zbytovský, J.; Zapletálek, M. 1989: Longitudinal study of the effect, tolerance and undesired side effects of injection haloperidol decanoate applied in different psychiatric indications Activitas Nervosa Superior 31(4): 266-267
Kobrzyńska, E.; Chachaj, L. 1982: Haloperidol in the treatment of psychotic disorders in old age Psychiatria Polska 16(1-2): 13-17
Friis, S. 1981: What kind of ward atmosphere is therapeutic for psychotic and non-psychotic patients? Necessity of differentiated treatment milieus Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 101(14): 848-852
Chandra, O.; Bernard, J.; Matussek, N. 1974: Long-term trial of fluphenazine decanoate and flupenthixol decanoate for cataleptic activity and effect on motor activity in rats Arzneimittel-Forschung 24(11): 1821-1824
Nagao, M.; Kanamori, M.; Takatori, T.; Terazawa, K.; Gotouda, H. 1987: An attempt on removal of haloperidol in plasma by use of anti-haloperidol immunoadsorbent Nihon Hoigaku Zasshi 41(3): 232-235
Kabes, J.; Balon, R.; Papezová, H. 1986: Maintenance therapy using clopenthixol decanoate in schizophrenic patients Ceskoslovenska Psychiatrie 82(3-4): 189-194
Drtil, J. 1989: Treatment of patients dependent on tobacco with fluphenazine decanoate Activitas Nervosa Superior 31(2): 116-117
Pérez Rasgado, S.; Wamba Magallanes, F.; Gómez Gil, R. 1977: Psychotic and non psychotic organic brain syndromes in the psychiatric service of a general hospital Archivos de Neurobiologia 40(2): 53-78
Tischler, S. 1979: Being with a psychotic child a psycho-analytical approach to the problems of parents of psychotic children International Journal of Psycho-Analysis 60(1): 29-38
Ando, K.; Hironaka, N.; Yanagita, T. 1986: Psychotic manifestations in amphetamine abuse--experimental study on the mechanism of psychotic recurrence Psychopharmacology Bulletin 22(3): 763-767
Mora, C.; Macía, M.L.; García, J.; Navarro, J.F. 2001: Effect of nandrolone decanoate on the lipid profile of male peritoneal dialysis patients Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 21(6): 611-614